KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Net Margin: 2010-2024

Historic Net Margin for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Dec 2024 value amounting to 11.16%.

  • Supernus Pharmaceuticals' Net Margin fell 4540.00% to -23.49% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.80%, marking a year-over-year decrease of 1195.00%. This contributed to the annual value of 11.16% for FY2024, which is 1094.00% up from last year.
  • According to the latest figures from FY2024, Supernus Pharmaceuticals' Net Margin is 11.16%, which was up 5,052.36% from 0.22% recorded in FY2023.
  • Over the past 5 years, Supernus Pharmaceuticals' Net Margin peaked at 24.39% during FY2020, and registered a low of 0.22% during FY2023.
  • Moreover, its 3-year median value for Net Margin was 9.10% (2022), whereas its average is 6.83%.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by 1,518bps in 2021, then skyrocketed by 1,094bps in 2024.
  • Over the past 5 years, Supernus Pharmaceuticals' Net Margin (Yearly) stood at 24.39% in 2020, then plummeted by 1,518bps to 9.21% in 2021, then fell by 12bps to 9.10% in 2022, then crashed by 888bps to 0.22% in 2023, then skyrocketed by 1,094bps to 11.16% in 2024.